No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Hyperammonemia is a condition caused by an excess of ammonia in the blood. It is a serious medical condition that can lead to coma and death if left untreated. Hematological drugs are used to treat hyperammonemia, as they can reduce the amount of ammonia in the blood. These drugs are typically administered intravenously or orally, and can be used to treat both acute and chronic hyperammonemia.
The hyperammonemia drug market is a rapidly growing sector of the pharmaceutical industry. It is driven by the increasing prevalence of hyperammonemia, as well as the development of new drugs to treat the condition. The market is expected to continue to grow in the coming years, as more drugs are developed and approved for use.
Some of the major companies in the hyperammonemia drug market include Merck & Co., Pfizer, Novartis, Sanofi, and GlaxoSmithKline. These companies are actively researching and developing new drugs to treat hyperammonemia, as well as marketing existing drugs to healthcare providers. Show Less Read more
